20/20 Biolabs, Inc. Share Price
NASDAQ: AIDX | Micro Cap20/20 Biolabs, Inc. Stock Performance
20/20 Biolabs, Inc. Share Price Today
As of 14 November 2026, 20/20 Biolabs, Inc.'s share price is $0.21. The stock opened at $0.20, compared to its previous close of $0.20. During today's trading session, 20/20 Biolabs, Inc.'s share price traded between $0.20 and $0.20, with an average price of $0.20. Over the past 52 weeks, the stock has recorded a high of $20.52 and a low of $0.19. In terms of performance, 20/20 Biolabs, Inc.'s share price has declined by 76.29% over the last six months and is down 94.26% on a year-on-year basis.
20/20 Biolabs, Inc. Share Price Chart
20/20 Biolabs, Inc. Quarterly Profit & Loss
All figures in USD
About 20/20 Biolabs, Inc.
20/20 Biolabs Inc is a commercial stage diagnostics company with the core mission of developing and commercializing clinical laboratory tests for early disease detection and prevention and associated software that is powered by machine learning and real-world data to improve diagnostic accuracy and clinical utility. The company offers two OneTest lab products; OneTest for Cancer that inludes primary MCED blood test and revenue source post-COVID and OneTest for Longevity that consists of inflammatory biomarkers.
20/20 Biolabs, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $0.22 | $0.20 | -6.64% |
Oct 2026 | $0.42 | $0.21 | -49.16% |
Sep 2026 | $0.56 | $0.41 | -33.06% |
Aug 2026 | $0.47 | $0.62 | +44.52% |
Jul 2026 | $0.59 | $0.43 | -21.86% |
Jun 2026 | $0.93 | $0.55 | -36.53% |
May 2026 | $1.60 | $0.86 | -43.09% |
Apr 2026 | $1.86 | $1.52 | -11.11% |
Mar 2026 | $3.53 | $1.71 | -52.17% |
Feb 2026 | $20.52 | $3.58 | N/A |